Option Care Health Sees Unusually High Options Volume (NASDAQ:OPCH)

Posted by Brenda Bartman on Oct 8th, 2026

Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) saw some unusual options trading activity on Tuesday. Traders purchased 5,219 call options on the stock. This is an increase of approximately 1,757% compared to the typical daily volume of 281 call options.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Weiss Ratings raised shares of Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Truist Financial set a $32.05 target price on Option Care Health in a research report on Wednesday. Stephens reaffirmed an “equal weight” rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $33.00 price objective on shares of Option Care Health in a research note on Wednesday. Three investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $29.70.

Check Out Our Latest Stock Analysis on Option Care Health

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $31.01 on Thursday. The company has a 50 day moving average of $23.92 and a 200 day moving average of $23.57. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.64 billion, a P/E ratio of 23.32, a P/E/G ratio of 1.79 and a beta of 0.58. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80.

Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.42 billion. During the same period in the prior year, the company posted $0.41 EPS. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, sell-side analysts forecast that Option Care Health will post 1.7 EPS for the current fiscal year.

Institutional Investors Weigh In On Option Care Health

Several large investors have recently added to or reduced their stakes in the business. Harbor Investment Advisory LLC bought a new position in Option Care Health in the 2nd quarter worth about $48,000. Nykredit A S bought a new stake in shares of Option Care Health during the 2nd quarter valued at about $56,000. Public Employees Retirement System of Ohio bought a new stake in shares of Option Care Health during the 2nd quarter valued at about $66,000. KBC Group NV grew its holdings in shares of Option Care Health by 22.1% during the first quarter. KBC Group NV now owns 5,453 shares of the company’s stock worth $147,000 after purchasing an additional 988 shares in the last quarter. Finally, Summitry LLC purchased a new position in shares of Option Care Health during the first quarter worth about $200,000. Institutional investors own 98.05% of the company’s stock.

Key Stories Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

Positive Sentiment: The definitive acquisition agreement provides a clear cash valuation and near-term potential for shareholders, while the stock’s trading below the $32.05 offer price leaves a merger-arbitrage spread if the transaction closes as planned. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
Positive Sentiment: Unusually heavy call-option activity and trading volume indicate significant speculative interest following the takeover announcement, although these signals do not guarantee additional gains. Option Care Health Rockets as CD&R and McKesson Table 37% Premium Bid
Neutral Sentiment: JPMorgan reaffirmed a Neutral rating with a $33 price target, while Citizens JMP and Barrington Research maintained Market Perform ratings. The targets suggest limited upside beyond the announced offer and reflect the likelihood that the deal, rather than operating performance, will determine the stock’s value.
Neutral Sentiment: Investors are booking gains and focusing on deal completion rather than standalone fundamentals. Zacks noted that recent earnings-estimate trends may not support further upside independent of the acquisition. Strength Seen in Option Care
Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 offer fairly values Option Care Health and whether insiders received benefits unavailable to public shareholders. Such reviews could increase deal-related uncertainty or encourage demands for a higher bid. Ademi LLP OPCH Shareholder Alert

About Option Care Health

(Get Free Report)

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.